Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2026-02-27 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 27th February 2026 from Sanofi India Limited addressed to stock exchanges. It informs about the uploading of the video recording of an Investors / Analysts Call held on 26th February 2026 discussing financial results for the quarter and year ended 31st December 2025. The document does not contain any financial data or detailed transcript but merely informs about the availability of the call recording. The length is only 1415 characters, indicating it is a brief notice rather than a full transcript or report. According to the rules, announcements about call recordings or meetings fall under Call Transcript (CT) if they contain the full transcript, but this document only announces the availability of the recording. Therefore, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement about the call recording availability, not the transcript itself or a financial report.
2026-02-27 English
Please find enclosed Annual Secretarial Compliance Report for the year ended 31st December 2025.
Regulatory Filings Classification · 95% confidence The document is titled 'Annual Secretarial Compliance Report for the year ended 31st December 2025' and is issued pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is a detailed compliance report by a practicing company secretary examining the company's adherence to various SEBI regulations and listing obligations for the specified fiscal year. The content includes compliance status, observations, and remedial actions related to secretarial standards and corporate governance. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an announcement or certification. This type of document is a regulatory compliance report specific to secretarial and governance compliance under SEBI regulations, which fits best under the category of Regulatory Filings (RNS) as it does not fall under other more specific categories and is a compliance report rather than a financial or management report.
2026-02-26 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter dated 26th February 2026 from the Company Secretary of Sanofi India Limited addressed to the stock exchanges (BSE and NSE). It announces the publication of the company's financial results for the quarter and year ended 31st December 2025 in newspapers. The letter encloses copies of the newspaper publication of these financial results and requests the exchanges to take the information on record. The document does not contain the financial results themselves but is an announcement of their publication in newspapers. The document length is about 15,000 characters, but the content is primarily an announcement and includes newspaper excerpts rather than a full financial report. According to the "Menu vs Meal" rule, such announcements that state the report is published or attached but do not contain the full report should be classified as Report Publication Announcement (RPA). Therefore, this document is best classified as a Report Publication Announcement (RPA).
2026-02-26 English
Please find enclosed copies of the Newspaper Publication of Financial Results for the quarter and year ended 31st December, 2025 of the Company published on 26th February 2026, in Business ....
Regulatory Filings Classification · 95% confidence The document is a letter dated 26th February 2026 addressed to stock exchanges (BSE and NSE) regarding the newspaper publication of financial results for the quarter and year ended 31st December 2025. It mentions that copies of the newspaper publication of financial results are enclosed and requests the exchanges to take the information on record. The document does not contain the actual financial results or detailed financial statements but is an announcement about the publication of these results in newspapers. This fits the description of an Earnings Release (ER) announcement but since it is a notification about the publication of results rather than the results themselves, and given the document length and content, it is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement of the publication of financial results rather than the results themselves or a full earnings release document. There is no indication of a full transcript, management discussion, or detailed financial data within the text. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2026-02-26 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is an investor/analyst call presentation dated 26th February 2026 for Sanofi India Limited, discussing financial results for the quarter and year ended 31st December 2025. It includes detailed financial performance data, business model transformation, R&D pipeline, sales, operating expenses, profit before tax, dividends proposal, and CSR initiatives. The document is a presentation intended for investors and analysts, as explicitly stated in the subject line and body. It is not a full annual report (10-K), nor an earnings release (ER) which would be a brief summary. It is not a transcript of the call but the presentation material used during the call. Therefore, the appropriate classification is Investor Presentation (IP). The document length and content support a high confidence score.
2026-02-26 English
Please find enclosed presentation that will be made at the investor call.
Interim / Quarterly Report Classification · 95% confidence The document is an investor/analyst call presentation dated 26th February 2026 for Sanofi India Limited, discussing financial results for the quarter and year ended 31st December 2025. It includes detailed slides on business model transformation, financial performance, sales data, operating expenses, profit before tax, dividends proposal, CSR initiatives, and strategic outlook. The document is explicitly described as a presentation to be made during the call and uploaded on the company's website for investors. It contains substantive financial data and analysis for the quarter and full year 2025, consistent with an Interim/Quarterly Report or Earnings Release. However, the detailed nature and length (over 12,000 characters) with comprehensive financial data and strategic commentary align more with an Interim/Quarterly Report (IR) rather than a brief Earnings Release (ER). The document is not merely an announcement or a certification but a full presentation with financial statements and analysis. Therefore, the most appropriate classification is Interim / Quarterly Report (IR).
2026-02-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.